Hong Kong Sanatorium & Hospital
12
2
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
2 terminated/withdrawn out of 12 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
17%
1 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
Role: lead
Total Lymphoid Irradiation as Conditioning for Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
Role: collaborator
Serological Response to mRNA and Inactivated COVID-19 Vaccine in Health Care Workers in Hong Kong
Role: lead
The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic
Role: lead
Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
Role: lead
Effect of a Third COVID-19 Booster Among Health Care Workers
Role: lead
Screening for Lung Cancer in Subjects With Family History of Lung Cancer
Role: collaborator
Pilot Study on Traditional Chinese Medicine and Food Allergy
Role: lead
Airway Navigation Database Asia for Diagnosis of Peripheral Pulmonary Nodules
Role: collaborator
Mast Cell Activation Test in Allergic Disease
Role: lead
Dietary Treatment for Chronic Urticaria
Role: lead
Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome
Role: lead
All 12 trials loaded